Breast cancer is the 2nd most common cancer among women. According to the National Breast Cancer Foundation, advancements in early detection methods and support continue to increase the chances of survival. When caught in its earliest, localized stages, the 5-year relative survival rate of breast cancer is 99%.
While the rate of breast cancer diagnosis is lower for Black women than for white women, Black women have a higher breast cancer death rate than any other racial or ethnic group in the United States. It is also the leading cause of cancer death for Latin women living in the U.S.
The Centers for Disease Control and Prevention (CDC) is actively working to reduce disparities through its National Breast and Cervical Cancer Early Detection Program that provides breast cancer screenings to low-income, uninsured, and underinsured women.
Telligen is also working to decrease health and healthcare disabilities for underserved populations. Visit our health equity page for additional information.